INTRODUCTION
============

Accurate differentiation between benign and malignant Neckorbital tumors is very important for the pre-treatment plan ([@B1]). Conventional computed tomography (CT) and magnetic resonance imaging (MRI) play an essential role in the display of normal structure and location of the orbital lesions; however, the role of conventional CT and MRI features in differentiating benign from malignant orbital tumors is limited ([@B2][@B3]). Diffusion-weighted imaging (DWI) allows quantification of the diffusion properties of water molecules ([@B4]), and its derived apparent diffusion coefficient (ADC) map is widely accepted as a useful tool to detect and characterize orbital lesions ([@B5][@B6][@B7][@B8][@B9]). Generally, due to the enlarged nuclei, hyper-cellularity, and subsequent limited extra-cellular space, malignant orbital tumors demonstrate lower ADC value than the benign tumors ([@B5][@B6][@B7][@B8][@B9][@B10]). However, the reproducibility of ADC measurements is still a challenge during clinical practice. Previous study has shown that ADC value can be affected by several factors, such as the magnetic field strength, MRI acquisition parameters, and also the region of interest (ROI) selection methods ([@B10]).

Previous DWI related studies have mainly utilized three kinds of ROI selection methods to obtain ADC values, including whole tumor ROI, single slice ROI, and reader-defined small sample ROI in selected slices ([@B11]). ROI on single or selected slice may lead to inter-reader variability, and does not reflect the tissue heterogeneity ([@B12]). Whole-tumor ROI can overcome this problem, however, it is a time consuming process, which limits its clinical application ([@B12]). The influence of ROI selection methods on the ADC measurements has been evaluated in the liver ([@B13]), ovaries ([@B14]), pancreas ([@B11][@B15]), and breast ([@B16]). However, to our knowledge, no previous study has addressed the influence of the three different ROI selection methods on the ADC measurements, and their diagnostic abilities for differentiating benign from malignant orbital tumors.

Therefore, the aim of our study was to assess the diagnostic performance of the ADC values based on different ROI selection methods in differentiating benign from malignant orbital tumors at 3T MR.

MATERIALS AND METHODS
=====================

Patients
--------

Institutional Review Board approval was obtained for this study, and the requirement for written informed consent was waived because of its retrospective nature. Our MRI database identified 124 consecutive patients who underwent DWI scan as part of pretreatment MRI evaluation for orbital tumors from March 2013 to December 2015. First, according to the definition of orbital indeterminate lesions proposed in previous studies ([@B5][@B9]), the patients of cavernous malformation (n = 30), lymphangioma (n = 1), venous varix (n = 5), and epidermoid cyst (n = 10) were excluded based on characteristic findings on conventional MRI. Six patients were excluded because the largest diameter of the lesion was \< 1 cm, 8 patients were excluded because of the poor image quality of DWI. Finally, 64 patients (36 men and 28 women; mean age, 49.8 ± 15.2 years; range, 18--90 years) were enrolled in our study.

Sixty-four patients contained 33 benign and 31 malignant tumors. Demographic and histological information of the two groups was shown in [Table 1](#T1){ref-type="table"}. The final diagnosis was made based on surgical pathology results in 58 patients, typical imaging features and long-term follow-up in 2 patients with optic nerve sheath meningioma, and follow-up after steroid treatment in 4 patients with inflammatory pseudotumor.

MR Scan
-------

MRI was performed using a 3T MR system (Verio; Siemens, Erlangen, Germany), with a twelve-channel head coil. Conventional MR images were acquired as follows: unenhanced axial T1-weighted imaging (repetition time \[TR\]/echo time \[TE\], 600/10 msec); axial, coronal and sagittal T2-weighted imaging (TR/TE, 4700/79 msec) with fat saturation; contrast-enhanced axial, coronal and sagittal T1-weighted imaging (TR/TE, 500/10 msec). For contrast-enhanced axial T1-weighted imaging, a standard dose of 0.1 mmol/kg of gadolinium-diethylene triamine pentaacetic acid (Magnevist; Bayer Schering Pharma AG, Berlin, Germany) was administered at a rate of 4 mL/s, followed by a 20-mL bolus of saline at the same injection rate.

Diffusion weighted imaging was obtained in the transverse plane using the single-shot spin-echo echo-planar sequence with three orthogonal diffusion gradients. Imaging parameters for DWI were as follows: TR/TE, 4000/85 ms; b factors, 0 and 800 s/mm^2^; section thickness, 4 mm with no gap; flip angle, 15°; field of view, 200 × 200 mm; matrix, 384 × 384; number of sections, 10; number of averages, 6. The total acquisition time of DWI was 4 minutes 14 seconds.

Imaging Analysis
----------------

Diffusion weighted imaging data were processed using an off-line in-house software (FireVoxel; CAI^2^R; New York University, New York, NY, USA) ([@B12]). The ADC map was constructed and the ADC value was calculated using the following mono-exponential fitting formula: ADC = -ln (S~b~/S~0~) / b, where b represents the diffusion sensitivity coefficients, and S~b~ and S~0~ represent the corresponding signal values of the given ROI.

When applying the whole-tumor ROI (ROI~WT~) method, freehand ROIs were drawn along the border of the high signal of the tumor on DWI (b = 800) to cover the entire tumor area on each tumor containing slice, and the mean ADC value was derived and defined as ADC-ROI~WT~. When applying single-slice ROI (ROI~SS~) method, the slice in which the tumor demonstrated the largest diameter was chosen. Free-hand ROIs were drawn to cover as much tumor tissue as possible in this slice. Similarly, the mean ADC value was derived and defined as ADC-ROI~SS~. When applying reader-defined small sample ROI (ROI~RDSS~) method, three freehand circular ROIs (area range, 0.467--0.622 cm^2^; mean, 0.506 cm^2^) were drawn on the area in which the tumor demonstrated relative higher signal intensity on DW image (b = 800). ADC values obtained from three ROIs were averaged for further analysis and designated ADC-ROI~RDSS~. For the three ROI methods, the visually cystic and necrotic areas were excluded with reference to T2-weighted and contrast enhanced T1-weighted images; and the time required for ADC measurements based on three different ROI methods was also recorded. Schematic illustration of the three different ROI selection methods was shown in [Figure 1](#F1){ref-type="fig"}.

Two experienced neuro-radiologists (reader 1 with 14 years of experience; reader 2 with 5 years of experience) independently measured the tumor ADC values according to the three ROI selection methods. The measurement results were averaged between the two readers for further analyses.

Statistical Analysis
--------------------

Numeric data were reported as mean ± standard deviation. Kolmogorov-Smirnov test was used for analyzing the normality of data distribution. Unpaired *t* test was used to compare the difference of age and mean ADC values between benign and malignant orbital tumors group. Chi-square test was used to compare the difference of gender between the two groups. Multiple receiver operating characteristic (ROC) curves comparison according to the method of DeLong et al. ([@B17]), were used to compare the diagnostic ability of the mean ADC values based on three different ROIs in predicting malignant orbital tumors. The times required for ADC measurement based on the three ROI selection methods were compared with ANOVA analysis. Inter-reader variability of orbital tumor ADC measurements for each ROI selection method was analyzed by using the intra-class correlation coefficient (ICC) ([@B18]), and the method of Bland-Altman ([@B19]). The statistical significance threshold was set at a two-sided *p* value \< 0.05. All statistical analyses were carried out using two statistical packages (SPSS version 19.0; SPSS Inc., Chicago, IL, USA and MedCalc version 13; MedClac Software, Ostend, Belgium).

RESULTS
=======

There was significant difference in age (*p* = 0.004), while no difference in gender (*p* = 0.825) between the benign and malignant groups. [Table 2](#T2){ref-type="table"} summarized the comparison of ADC-ROI~WT~, ADC-ROI~SS~, and ADC-ROI~RDSS~ value between benign and malignant group. Malignant group demonstrated lower mean ADC-ROI~WT~, ADC-ROI~SS~, and ADC-ROI~RDSS~ value than benign group (ADC-ROI~WT~, 0.808 ± 0.280 vs. 1.795 ± 0.470, *p* \< 0.001; ADC-ROI~SS~, 0.773 ± 0.230 vs. 1.754 ± 0.461, *p* \< 0.001; ADC-ROI~RDSS~, 0.675 ± 0.213 vs. 1.605 ± 0.423, *p* \< 0.001). Comparison of ADC-ROI~WT~, ADC-ROI~SS~, and ADC-ROI~RDSS~ value between the two groups was also shown in box plots ([Fig. 2](#F2){ref-type="fig"}).

The average time required for ADC-ROI~WT~, ADC-ROI~SS~, and ADC-ROI~RDSS~ measurement was 82.1 ± 26.3, 30.0 ± 6.5, and 31.5 ± 8.3 seconds. The time required for ADC-ROI~WT~ measurement was significantly longer than ADC-ROI~SS~ and ADC-ROI~RDSS~ (both *p* \< 0.001), while no significant difference was found in the time required for ADC-ROI~SS~ and ADC-ROI~RDSS~ (*p* = 0.093).

Receiver operating characteristic curves analysis indicated that setting the ADC-ROI~WT~ = 1.251 × 10^-3^ mm^2^/s, ADC-ROI~SS~ = 1.084 × 10^-3^ mm^2^/s, ADC-ROI~RDSS~ = 1.140 × 10^-3^ mm^2^/s as threshold value resulted in optimal diagnostic value {(ADC-ROI~WT~; area under curve \[AUC\], 0.948; sensitivity, 96.8%; specificity, 84.9%) (ADC-ROI~SS~; AUC, 0.966; sensitivity, 93.6%; specificity, 90.9%) (ADC-ROI~RDSS~; AUC, 0.969; sensitivity, 100%; specificity, 84.9%)}. Multiple ROC curves comparison indicated that the AUCs showed no significant differences when using ADC-ROI~WT~, ADC-ROI~SS~, and ADC-ROI~RDSS~ as differentiating index, respectively (ADC-ROI~WT~ vs. ADC-ROI~SS~, *p* = 0.073; ADC-ROI~SS~ vs. ADC-ROI~RDSS~, *p* = 0.610; ADC-ROI~WT~ vs. ADC-ROI~RDSS~, *p* = 0.064). ROC analyses using ADC-ROI~WT~, ADC-ROI~SS~, and ADC-ROI~RDSS~ to predict orbital malignancy were showed in [Table 3](#T3){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}.

The mean difference (bias) and limits of agreement between two readers were 0.022 (-0.080--0.123) × 10^-3^ mm^2^/s for single-slice ROI (ICC, 0.997; 95% confidence interval \[CI\], 0.994--0.998), 0.024 (-0.245--0.292) × 10^-3^ mm^2^/s for ROI~WT~ (ICCs, 0.977; 95% CI, 0.962--0.986), and 0.192 (-0.135--0.518) × 10^-3^ mm^2^/s for small solid sample ROI (ICC, 0.959; 95% CI, 0.933--0.974). The mean ADCs in small solid sample ROI were more scattered than the other two ROI methods. Graphic illustrations of these data with Bland-Altman plots were displayed in [Figure 4](#F4){ref-type="fig"}.

DISCUSSION
==========

In this study, we compared the mean ADC values derived from three different ROI selection methods of the benign and malignant orbital tumors. ADC values based on the three ROI selection methods of the malignant orbital tumors were significantly lower than those of the benign tumors. In addition, ROI~SS~ showed the best reproducibility among three ROI selection methods; whereas, the ROI~SS~ and ROI~RDSS~ showed significantly shorter measurement time than ROI~WT~. Based on the measurement time, reproducibility and diagnostic ability, ROI~SS~ has the potential for use in measurement of the ADC value of orbital tumors in clinical practice.

The present results demonstrated that ADC values based on the three different ROI selection methods of the malignant orbital tumors were significantly lower than those of the benign tumors. Enlarged nuclei and hyper-cellularity in malignant tumors would reduce the diffusivity of water protons in the extracellular and intracellular space, and result in decreased ADC values ([@B5][@B8][@B9]). In addition, despite variation in diagnostic performance of the ADC values based on the three ROI selection methods, the AUC values from ROC analyses showed no significant difference among these three methods. Our study results indicated that ADC values based on the three ROI selection methods might be useful metrics for predicting orbital malignancy.

Each ROI selection method has its own merits and limitations. During clinical usage, ROI~RDSS~ was the most commonly used ROI selection method for measuring the ADC values. Previous studies indicated that since the ROI~RDSS~ was commonly placed on the area where the tumor showed relative higher signal intensity on DW images, ROI~RDSS~ tended to reflect the most solid, cellular or viable portion of the tumor ([@B11][@B20]). However, our study results indicated that inter-reader variability was an major limitation of ROI~RDSS~. To overcome this limitation, some researchers proposed the ROI~WT~ approach ([@B5][@B7][@B12]). However, since the ROI~WT~ approach is a time-consuming process, much longer measurement time could be a limitation for its routine application in clinical practice. In contrast, the ROI~SS~ had significantly better reproducibility than ROI~RDSS~, and significantly shorter measurement time than ROI~WT~. Thus, the ROI~SS~ would be the most appropriate approach to measure ADC values of orbital tumors in clinical practice.

Our study has some limitations. First, the study population was relatively small. Future studies are required to validate the present results in a larger population. Second, final diagnosis of some cases was based on the typical imaging appearance and long-term follow-up or diagnostic treatment, without histological conformation. Third, 8 of 124 DWI studies could not be interpreted due to inadequate image quality. Future study using periodically rotated overlapping parallel lines with enhanced reconstruction technique or readout-segmented echo-planar imaging technique might be helpful to reduce the artifacts ([@B9][@B21]).

In conclusion, our study showed that the ADC values derived from all three ROI selection methods could help to differentiate benign from malignant orbital tumors. The ROI selection methods had no definite influence on the diagnostic performance of ADC values.

The results of measurement time, reproducibility and diagnostic ability suggest that the ROI~SS~ method could be used to measure the ADC value of orbital tumors in clinical practice.

![Schematic illustration of three ROI selection methods on DW (b = 800 s/mm^2^) images obtained from 70-year-old patient with orbital lymphoma.\
Axial T2-weighted image shows lesion molding in right orbit **(A)**. For reader-defined small sample ROI, three freehand circular ROIs with mean area of approximately 0.5 cm^2^ were drawn on area in which tumor showed relative higher signal intensity on DW image (b = 800) **(B)**. For selected slice ROI, slice in which tumor showed largest diameter was chosen. Free-hand ROIs was drawn to cover as much tumor tissue as possible in this slice **(C)**, then corresponding ADC map could be generated and embed within DW image **(D)**. For whole-tumor ROI, freehand ROIs were drawn along border of tumor to cover entire tumor area on each tumor-containing slice (**E,** four maps). ADC = apparent diffusion coefficient, DW = diffusion weighted, ROI = regions of interest](kjr-17-650-g001){#F1}

![Box-and-whisker plots of ADC-ROI~WT~ (A), ADC-ROI~SS~ (B), and ADC-ROI~RDSS~ (C) values between benign and malignant groups.\
^\*^Outliers. ADC = apparent diffusion coefficient, ROI = region of interest, ROI~RDSS~ = ROI based on reader-defined small sample in selected slices, ROI~SS~ = ROI based on single slice, ROI~WT~ = ROI based on whole tumor](kjr-17-650-g002){#F2}

![**ROC analyses using ADC-ROI~WT~ (A), ADC-ROI~SS~ (B), and ADC-ROI~RDSS~ (C) values to differentiate benign from malignant orbital tumors.** Multiple ROC curves comparison indicated no significant differences on area under curves when using ADC-ROI~WT~, ADC-ROI~SS~, and ADC-ROI~RDSS~ as differentiating index, respectively (ADC-ROI~WT~ vs. ADC-ROI~SS~, *p* = 0.073; ADC-ROI~SS~ vs. ADC-ROI~RDSS~, *p* = 0.610; ADC-ROI~WT~ vs. ADC-ROI~RDSS~, *p* = 0.064). ADC = apparent diffusion coefficient, AUC = area under curve, ROC = receiver operating characteristic, ROI = region of interest, ROI~RDSS~ = ROI based on reader-defined small sample in selected slices, ROI~SS~ = ROI based on single slice, ROI~WT~ = ROI based on whole tumor](kjr-17-650-g003){#F3}

![**Bland-Altman plots of inter-reader agreement for ADC-ROI~WT~ (A), ADC-ROI~SS~ (B), and ADC-ROI~RDSS~ (C).** Difference of mean ADC value between two readers (y-axis) was plotted against mean ADC value of two readers (x-axis), with mean absolute difference (bias) (solid line) and 95% confidence interval of mean difference (limits of agreement) (dashed lines). ADC = apparent diffusion coefficient, ROI = region of interest, ROI~RDSS~ = ROI based on reader-defined small sample in selected slices, ROI~SS~ = ROI based on single slice, ROI~WT~ = ROI based on whole tumor](kjr-17-650-g004){#F4}

###### Demographic and Histological Information between Two Groups

![](kjr-17-650-i001)

  Variables                           Benign Group (n = 33)            Malignant Group (n = 31)   *P*
  ----------------------------------- -------------------------------- -------------------------- -------
  Age (years)                         44.5 ± 12.9                      55.4 ± 15.7                0.004
  Gender (M/F)                        19/14                            17/14                      0.825
  Diagnosis                           Inflammatory pseudotumor (10)    Lymphoma (22)              \-
  Pleomorphic adenoma (9)             Adenoid cystic carcinoma (2)                                
  Schwannoma (6)                      Metastases (3)                                              
  Optic nerve sheath meningioma (4)   Basal cell carcinoma (1)                                    
  IgG4-related disease (3)            Lymphoepithelial carcinoma (1)                              
  Solitary fibrous tumor (1)          Ewing sarcoma (1)                                           
                                      Melanoma (1)                                                

Data in parentheses indicates number of corresponding patients in our study. F = female, IgG4 = immunoglobulin G4, M = male

###### Comparison of ADC between Two Groups

![](kjr-17-650-i002)

  ADC Value       Benign Group (n = 33)   Malignant Group (n = 31)   *P*
  --------------- ----------------------- -------------------------- ----------
  ADC-ROI~WT~     1.795 ± 0.470           0.808 ± 0.280              \< 0.001
  ADC-ROI~SS~     1.754 ± 0.461           0.773 ± 0.230              \< 0.001
  ADC-ROI~RDSS~   1.605 ± 0.423           0.675 ± 0.213              \< 0.001

Data are reported as mean ± standard deviation; unit for ADC value is × 10^-3^ mm^2^/s. ADC = apparent diffusion coefficient, ROI = region of interest, ROI~RDSS~ = ROI based on reader-defined small sample in selected slices, ROI~SS~ = ROI based on single slice, ROI~WT~ = ROI based on whole tumor

###### Diagnostic Ability of ADC Based on Different ROIs for Predicting Orbital Malignancy

![](kjr-17-650-i003)

  Variables        Cut-Off Value   AUC                    Sensitivity (%)     Specificity (%)
  ---------------- --------------- ---------------------- ------------------- -------------------
  ADC value                                                                   
   ADC-ROI~WT~     1.251           0.948 (0.862--0.988)   96.8 (83.3--99.9)   84.9 (68.1--94.9)
   ADC-ROI~SS~     1.084           0.966 (0.887--0.995)   93.6 (78.6--99.2)   90.9 (75.7--98.1)
   ADC-ROI~RDSS~   1.140           0.969 (0.892--0.996)   100 (88.8--100)     84.9 (68.1--94.9)

Data in parentheses are 95% confidence intervals. Unit for ADC value is × 10^-3^ mm^2^/s. ADC = apparent diffusion coefficient, AUC = area under curve, ROI = region of interest, ROI~RDSS~ = ROI based on reader-defined small sample in selected slices, ROI~SS~ = ROI based on single slice, ROI~WT~ = ROI based on whole tumor
